Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by walkingredon Apr 09, 2017 10:45am
290 Views
Post# 26097446

RE:RE:RE:AGM and share consolidation

RE:RE:RE:AGM and share consolidationThe RS has been muddled over for years.  The talk has picked up again lately and for all the talk of organic growth and it's not really an option, more just a formality.  GARBAGE.

Why would anyone other than the fat cats support the reverse split.. In theory it sucks used only when the stock has no momentum and is falling beyond certain levels, like a mad scramble to gather the pieces.

In reality they're trying to sugar coat it by saying Nasdaq, and 10$, less volatility blah blah blah.  My A$$.

The RS will be the worst thing this company could do for itself, and it's investors...seeing the ratio go up from 1-4 to 1-6.... someone mentioned 1-10.  That is ridiculous and I would be livid. Don't give a sh!!t if the meds work or not either.... it's called shafting the investor and it isn't cool.

If they do it for the purpose of getting listed on Nasdaq...watch this thing get driven right into the ground.

IMHO that you can all write off and most will. 
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse